Cholinergic receptors at the motor end-plate — Drug Target

All drugs that target Cholinergic receptors at the motor end-plate — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nondepolarizing neuromuscular blocking agent

Marketed (1)

• Rocuronium · Merck & Co. · Nondepolarizing neuromuscular blocking agent · Neuroscience
  Rocuronium bromide competes for cholinergic receptors at the motor end-plate, antagonized by acetylcholinesterase inhibitors.